Replies to post #684028 on NorthWest Biotherapeutics Inc (NWBO)

[User-840664]

It's worth about what they paid for it.... About $4 million
Advent is the cash cow.... IMO

[flipper44]

90% of the production space at Sawston is NWBO’s/Flaskwork’s not Advent/Toucans, and Advent is a contractor for NWBO. Maybe you should just rest a while.

Flaskworks is very valuable as it will soon, under its patents, following Advent, commercially make DCVax, if approved, which will also be protected under biologic exclusive use and data exclusive use, as well as combination protection.

And DCVax-Direct has patent protection out to 2036.

[norisknorewards]

don't ignore me, i know you saw what you did there.

[iclight]

LP will find a way to make Flaskworks NEVER worth anything to NWBO, only to herself. Just like Cognate.

[learningcurve2020]

Is there any annual rent increase that can help out the share price? LOL

[User-840664]

Flaskworks is barely out of the prototype phase.. Still needs to be built, and approved! Advent is cruising

[biosectinvestor]

Only a portion of the facility, the old technology part, and that will be used most likely to fulfill the company’s obligation to the regional funding authority that bankrolled creating Sawston. The development comes in phases and Sawston does not own it, they lease and provide services in a minor footprint and for now, they are the contract manufacturer in that footprint. The arrangement is totally rational, minimizes risk and is flexible for the company, something a predecessor firm did not do, and it got that company into trouble that this company has completely avoided.

[drugrunner]

IT GUY ex claiming flashworks is useless

Who to believe ??

[antihama]

Erroneous argument in comparing Flaskworks to other automated closed cell manufacturing systems. You just need to know that it is priceless in the manufacture of DCVax-L and making it ~12x more efficient than the manual method which is, well, priceless. Those other automated closed cell manufcaturing systems CAN'T make DCVax-L just likes NWBOs semi automated system for Direct, tangential flow filtration, can't make L. An apples to oranges argument.

Hard to know if Flaskworks is worth much of anything with all the other already approved automated closed cell manufcaturing systems already commercially available though.